Covidien reports strong Q4 for devices division, but profit plunges
This article was originally published in Clinica
Executive Summary
Sales by Covidien’s medical devices division outpaced other segments of the company in the fourth quarter of fiscal 2009, growing 7% to reach $1.6bn.